DOJOLVI

Ultragenyx Pharmaceutical Inc.

Application Filed: 2019-03-22

Trademark Application Details

Mark For: DOJOLVI® trademark registration is intended to cover the categories of pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD). [all]

Status

2020-07-08 UTC

LIVE APPLICATION Under Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.

Research	OneLook Acronym Finder
Serial Number	88352451
Registration Number	6176000
Mark Literal Elements	DOJOLVI
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	INTENT TO USE SECTION 2019-09-03
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Anne H. Peck
Attorney Docket Number	315613-20000
Law Office Assigned	L40
Employee Name	CHADAB, SETH WILLIG

Timeline

2019-03-22	Application Filed
2019-07-09	Published
2019-07-09	Published for Opposition
2019-09-03	Location: INTENT TO USE SECTION
2019-12-20	Status: A first request for extension of time to file a Statement of Use has been granted.
2019-12-20	Status: Live/Pending
2019-12-24	Transaction Date
2020-10-13	Trademark Registered

Trademark Parties (Applicants & Owners)

Party:	Ultragenyx Pharmaceutical Inc.
Address	60 Leveroni Court Novato, CALIFORNIA UNITED STATES 94949
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Drawing	JPEG	2019-03-22
TEAS RF New Application	MULTI	2019-03-22
Notation to File	XML	2019-06-03
Notation to File	XML	2019-06-03
XSearch Search Summary	XML	2019-06-03
TRAM Snapshot of App at Pub for Oppostn	MULTI	2019-06-04
Notice of Publication	XML	2019-06-19
Notification Of Notice of Publication	XML	2019-06-19
OG Publication Confirmation	APPLICATION/XML	2019-07-09
Post Publication Amendment	XML	2019-08-14
Amendment and Mail Process Complete	MULTI	2019-08-30
Notice of Allowance	APPLICATION/XML	2019-09-03
Extension of Time to File SOU	XML	2019-12-20
ITU Extension Approval	XML	2019-12-24
ITU Unit Action	MULTI	2019-12-24

Attorney of Record

Anne H. Peck
Cooley LLP
Suite 700
1299 Pennsylvania Avenue, N.W.
Washington, DC 20004

Good, Services, and Codes

IC 005. US 006 018 044 046 051 052. G & S: pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)
GS0051	pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)

Trademark Filing History

Description	Date	Proceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-12-24
TEAS EXTENSION RECEIVED	2019-12-20
EXTENSION 1 GRANTED	2019-12-20	98765
EXTENSION 1 FILED	2019-12-20	98765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2019-09-03
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED	2019-08-29	86882
ASSIGNED TO PETITION STAFF	2019-08-27	86882
TEAS POST PUBLICATION AMENDMENT RECEIVED	2019-08-14	1111
PUBLISHED FOR OPPOSITION	2019-07-09
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2019-07-09
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2019-06-19
ASSIGNED TO EXAMINER	2019-06-03	92449
APPROVED FOR PUB - PRINCIPAL REGISTER	2019-06-03
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2019-04-10
NEW APPLICATION ENTERED IN TRAM	2019-03-26

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
DOJOLVI 88707194 not registered Live/Pending	Ultragenyx Pharmaceutical Inc. 2019-11-26
DOJOLVI 88352451 not registered Live/Pending	Ultragenyx Pharmaceutical Inc. 2019-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.